print PRINT

SCIENCE > Health

Japan authorizes emergency use of oral COVID-19 drug 

  • December 25, 2021
  • , All national papers
  • JMH Summary

The Saturday editions of all national dailies reported that the Health Ministry on Friday approved the use of a COVID-19 pill called Molnupiravir manufactured by Merck on an exceptional basis, saying that the medication will be made available to patients as early as Sunday. Japan has already secured 1.6 million doses of the drug in the hope of mitigating the potential strain on hospitals by enabling patients with minor symptoms to recuperate at home.  

  • Ambassador
  • Ukraine
  • COVID-19
  • Trending Japan